Publications

rachaelpung/temporal_networks.

PUNG, R; KUCHARSKI, AJ; Firth, J; RUSSELL, TW; Rogers, T; Lee, V;

2024

, Zenodo (2024).

Invited speaker – WHO Product Development for Vaccines Advisory Committee (PDVAC), Geneva, 2024.

Richard, W;

2024

(2024).

Using models and maps to inform Target Product Profiles and Preferred Product Characteristics: the example of Wolbachia replacement.

TILEY, K; Entwistle, J; Thomas, B; Yakob, L; BRADY, O;

2024

Gates open research, (2024).7 68 10.12688/gatesopenres.14300.3.

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.

Chang, VK; Imperial, MZ; Phillips, PP J; Velásquez, GE; Nahid, P; Vernon, A; Kurbatova, EV; Swindells, S; Chaisson, RE; Dorman, SE; Johnson, JL; Weiner, M; Jindani, A; Harrison, T; Sizemore, EE; Whitworth, W; Carr, W; Bryant, KE; Burton, D; Dooley, KE; Engle, M; Nsubuga, P; Diacon, AH; Nhung, NV; Dawson, R; ... Tuberculosis Trials Consortium,

2024

Nature communications, (2024).15 1 10.1038/s41467-024-53273-7.

The 2024 report of the Lancet Countdown on health and climate change: facing record-breaking threats from delayed action.

Romanello, M; Walawender, M; Hsu, S-C; Moskeland, A; Palmeiro-Silva, Y; Scamman, D; ALI, Z; Ameli, N; Angelova, D; Ayeb-Karlsson, S; Basart, S; Beagley, J; Beggs, PJ; Blanco-Villafuerte, L; Cai, W; Callaghan, M; Campbell-Lendrum, D; Chambers, JD; Chicmana-Zapata, V; Chu, L; Cross, TJ; Van Daalen, KR; Dalin, C; Dasandi, N; Dasgupta, S; ... Costello, A.

2024

Lancet (London, England), (2024).404 10465 10.1016/S0140-6736(24)01822-1.

Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+ decline.

Baxter, J; Villabona-Arenas, CJ; Thompson, RN; Hué, S; Regoes, RR; Kouyos, RD; Günthard, HF; Albert, J; Leigh Brown, A; ATKINS, KE;

2024

Journal of the Royal Society, Interface / the Royal Society, (2024).21 219 10.1098/rsif.2024.0255.

Chikungunya vaccine development, challenges, and pathway toward public health impact.

Maure, C; Khazhidinov, K; KANG, H; AUZENBERGS, M; Moyersoen, P; ABBAS, K; Santos, GM L; Medina, LM H; Wartel, TA; Kim, JH; Clemens, J; Sahastrabuddhe, S;

2024

Vaccine, (2024).42 26 10.1016/j.vaccine.2024.126483.

Best practices for estimating and reporting epidemiological delay distributions of infectious diseases.

Charniga, K; Park, SW; Akhmetzhanov, AR; Cori, A; Dushoff, J; FUNK, S; Gostic, KM; Linton, NM; Lison, A; Overton, CE; Pulliam, JR C; Ward, T; Cauchemez, S; ABBOTT, S;

2024

PLoS computational biology, (2024).20 10 10.1371/journal.pcbi.1012520.

Quantifying the impact of norovirus transmission in the community on acute kidney injury hospitalisations in England: a mathematical modelling study.

BOLT, H; Gupte, P; Douglas, A; Sandmann, F; Tomlinson, L; EGGO, R;

2024

medRxiv (2024). 10.1101/2024.10.24.24316053.

Africa Health Research Institute (AHRI) Household Contact study: a study protocol, statistical analysis and modelling plan.

KHAN, PY; GOVENDER, I; MCCREESH, N; SWEENEY, S; Sithole, M; Ording-Jespersen, G; Buthelezi, X; HOUBEN, RM G J; BAISLEY, K; Smit, T; Wong, EB; Hanekom, W; WHITE, RG; Vassall, A; FIELDING, K; GRANT, AD;

2024

Wellcome open research, (2024).9, 10.12688/wellcomeopenres.22974.1.